Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT)
Launched by UNIVERSITY OF BRITISH COLUMBIA · May 25, 2021
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
The TRAIL-RCT trial is studying how effective a 4-week telerehabilitation program can be for improving movement and function in the legs of adults who have had a stroke. This program uses digital technology to provide rehabilitation exercises that patients can do at home, compared to a 4-week education program where participants receive general information but no physical exercises. The goal is to see which approach better helps people recover, improves their quality of life, and uses healthcare resources more efficiently.
To join this study, participants need to be at least 19 years old and have experienced a stroke within the past year, resulting in weakness in one leg. They should be able to walk at least 10 meters, with or without a walking aid, and can handle 50 minutes of activity with some rest. Participants will need a caregiver or family member to assist them during the assessment sessions. Those currently in rehabilitation for leg training, living in long-term care, or having serious health issues may not be eligible. If you decide to participate, you can expect to engage in a program designed to help you regain leg function while being supported from the comfort of your home.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥19 years of age, ≤12 months post-stroke with lower extremity hemiparesis
- • Able to walk ≥10 meters with or without a gait aid and without physical assistance of another person
- • Can tolerate 50 minutes of activity (including rest breaks)
- • Has cognitive-communicative ability to participate, per clinical judgement
- • Able to provide consent
- • Has a caregiver, friend, or family member available to provide physical support during the assessment sessions
- Exclusion Criteria:
- • Currently participating in formal in- or out-patient stroke rehabilitation focusing on lower extremity training
- • Living in long-term care
- • Severe vision or hearing loss
- • Significant musculoskeletal or other neurological conditions
- • Not medically stable
- • Comorbidities (e.g. limb amputation), pain or other symptoms that significantly impact lower extremity function
- • Planned surgery that would preclude or affect participation in the protocol
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Vancouver, British Columbia, Canada
London, Ontario, Canada
Winnipeg, Manitoba, Canada
Nova Scotia, Halifax, Canada
Patients applied
Trial Officials
Brodie Sakakibara, PhD
Principal Investigator
University of British Columbia
Ada Tang, PhD
Principal Investigator
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials